HIV-1 capsid inhibitor and antiretroviral medicine
Nigeria has achieved 96% viral load suppression among people on antiretroviral therapy with recent data showing suppression above the UNAIDS 95% target. The 96% figure comes from Nigeria's national data repository for patients who had a viral load test in the past 12 months. Experts say the next task is locating the remaining 4% not suppressed and ensuring no one is left behind in the HIV response.
Uganda reports HIV prevalence stable at 5.9% with 1.496 million adults living with HIV; 85.3% know their status, 99.1% on treatment, 96.5% virally suppressed. In MENA, lenacapavir's global rollout shows affordability gaps and uneven access; six generic manufacturers will produce cheaper versions, but many countries remain excluded, raising concerns over reach of the prevention option.